TD Private Client Wealth’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$610K Buy
1,309
+171
+15% +$71.9K 0.01% 458
2026
Q1
$430K Sell
1,138
-512
-31% -$219K 0.01% 510
2025
Q4
$706K Sell
1,650
-565
-26% -$246K 0.02% 412
2025
Q3
$992K Sell
2,215
-540
-20% -$245K 0.02% 365
2025
Q2
$1.34M Sell
2,755
-16
-0.6% -$9.12K 0.03% 304
2025
Q1
$1.71M Sell
2,771
-64
-2% -$36.4K 0.05% 255
2024
Q4
$1.5M Sell
2,835
-41
-1% -$23.1K 0.04% 279
2024
Q3
$1.73M Sell
2,876
-21
-0.7% -$11.9K 0.05% 267
2024
Q2
$1.57M Sell
2,897
-138
-5% -$79K 0.05% 277
2024
Q1
$1.95M Buy
3,035
+29
+1% +$17.6K 0.06% 243
2023
Q4
$1.76M Sell
3,006
-17
-0.6% -$9.51K 0.06% 239
2023
Q3
$1.57M Sell
3,023
-372
-11% -$193K 0.07% 249
2023
Q2
$1.84M Sell
3,395
-5
-0.1% -$2.73K 0.08% 237
2023
Q1
$1.83M Sell
3,400
-96
-3% -$49K 0.08% 234
2022
Q4
$1.78M Sell
3,496
-265
-7% -$129K 0.08% 235
2022
Q3
$1.64M Sell
3,761
-192
-5% -$92.3K 0.08% 231
2022
Q2
$1.86M Sell
3,953
-169
-4% -$82.4K 0.09% 218
2022
Q1
$2.09M Buy
4,122
+643
+18% +$308K 0.09% 225
2021
Q4
$1.84M Sell
3,479
-381
-10% -$183K 0.08% 245
2021
Q3
$1.8M Sell
3,860
-314
-8% -$148K 0.08% 249
2021
Q2
$1.98M Buy
4,174
+29
+0.7% +$13.9K 0.08% 240
2021
Q1
$1.91M Buy
4,145
+442
+12% +$217K 0.09% 233
2020
Q4
$1.97M Buy
3,703
+230
+7% +$113K 0.1% 216
2020
Q3
$1.67M Buy
+3,473
New +$1.7M 0.09% 217

Other funds holding CHE

TD Private Client Wealth's CHE Position: Q2 2026 in Review

TD Private Client Wealth increased its Chemed (CHE) stake by 15% in Q2 2026, buying an estimated $71.9K and bringing the position to 1,309 shares worth $610K. The position accounts for 0.01% of the portfolio, ranked #458.

TD Private Client Wealth first reported a position in CHE in Q3 2020 and has held it in 24 quarters since. The position peaked at $2.09M in Q1 2022. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • TD Private Client Wealth held 1,309 shares of Chemed worth $610K as of Q2 2026.
  • TD Private Client Wealth bought 171 Chemed shares in Q2 2026, an estimated $71.9K.
  • Chemed made up 0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #458 holding.
  • TD Private Client Wealth first reported a position in Chemed in Q3 2020 and has held it in 24 quarters since.
  • TD Private Client Wealth's Chemed position peaked at $2.09M in Q1 2022.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.